Hexanoate

Hexanoate

SCHEMBL7141372

CCCCCC(=O)O.Cc1[nH]c2ccc(NC(=S)N3CCN(C)CC3)cc2c1CCNCc1cnc2ccccc2n1

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 15/20 0.40
MAPT P10636 13/20 0.40
ALDH1A1 P00352 11/20 0.40
GAA P10253 10/20 0.40
RAD52 P43351 5/20 0.39
LMNA P02545 4/20 0.38
HTT P42858 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
RAB9A P51151 2/20 0.36
KMT2A Q03164 2/20 0.36
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
RECQL P46063 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
BLM P54132 2/20 0.35
PKM P14618 1/20 0.35
TP53 P04637 1/20 0.35
POLB P06746 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexanoate SCHEMBL8553500 0.87 KDM4E (0.40) KDM4EMAPTALDH1A1GAARAD52
Hexanoate SCHEMBL8551431 0.87 KDM4E (0.40) KDM4EMAPTALDH1A1GAARAD52
Hexanoate SCHEMBL8180689 0.76 TLR9 (0.41) MAPTALDH1A1SMN1; SMN2RAB9AKMT2A
Hexanoate SCHEMBL8190714 0.74 HTR1F (0.39) KDM4EMAPTALDH1A1SMN1; SMN2RAB9A
Hexanoate SCHEMBL7146845 0.71 HTR1F (0.38) KDM4EMAPTALDH1A1GAALMNA
SCHEMBL8931360 0.66 MLLT1 (0.42) KDM4EALDH1A1RAB9AKMT2AMEN1
Acetic Acid SCHEMBL7142201 0.65 BRD4 (0.43) KDM4EMAPTALDH1A1RAD52KMT2A
SCHEMBL7139432 0.64 HTR1F (0.61) MAPTSMN1; SMN2RAB9AKMT2AMEN1
Acetic Acid SCHEMBL8192311 0.64 HTR1F (0.42) KDM4EMAPTALDH1A1SMN1; SMN2RAB9A
Hexanoate SCHEMBL8547299 0.63 CNR2 (0.39) MAPTALDH1A1SMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768301-B1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists LILLY CO ELI (US) 2003-04-02 EP disclosed
US-6126932-A INSOLUBLE POLYMER BEARING PENDANT SIDE CHAINS, SAID SIDE CHAINS EACH TERMINATING WITH THE 1-(3-(1-PYRROLIDINYL)-PROPYL)-3-ETHYLCARBODIIMIDE MOIETY. ELI LILLY AND COMPANY (US) 2000-10-03 US disclosed
US-5998630-A A 1-(3-(1-PYRROLIDINYL)PROPY)-3-ETHYLCARBODIIMIDE ELI LILLY AND COMPANY (US) 1999-12-07 US disclosed
US-5942536-A USEFUL FOR TREATING MIGRAINE ELI LILLY AND COMPANY (US) 1999-08-24 US disclosed
EP-0768301-A1 N-(2-substituted-3-(2-aminoethyl)-1H-indol-5-yl)-amides as new 5-HT1F agonists ELI LILLY AND COMPANY (US) 1997-04-16 EP disclosed